HLA-B58 can help the clinical decision on starting allopurinol in patients with chronic renal insufficiency

Strong association between HLA-B*5801 and allopurinol-induced Stevens–Johnson syndrome and toxic epidermal necrolysis in a Thai population

(2009) Wichittra Tassaneeyakul et al.   Pharmacogenetics and Genomics

New insights into the epidemiology of gout

(2009) M. Doherty   RHEUMATOLOGY

Should HLA‐B*5701 Screening Be Performed in Every Ethnic Group before Starting Abacavir?

(2008) Wan Beom Park et al.   CLINICAL INFECTIOUS DISEASES

A European study of HLA-B in Stevens???Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs

(2008) Christine Lonjou et al.   Pharmacogenetics and Genomics

HLA-B locus in Japanese patients with anti-epileptics and allopurinol-related Stevens–Johnson syndrome and toxic epidermal necrolysis

(2008) Nahoko Kaniwa et al.   PHARMACOGENOMICS

Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: Assessment of Medication Risks with Emphasis on Recently Marketed Drugs. The EuroSCAR-Study

(2007) Maja Mockenhaupt et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY